Ex parte ELOKDAH et al. - Page 2




             Appeal No. 1997-1965                                                                                     
             Application No. 08/466,482                                                                               


                                              THE APPEALED CLAIMS                                                     
                    The appealed claims read as follows:                                                              
             18.    A pharmaceutical composition comprising a compound of formula I or II:                            








             wherein                                                                                                  
                    R is alkyl of 1 to 6 carbon atoms, phenyl, benzyl, or substituted phenyl or substituted           
             benzyl, in which the substituents are halogen, hydroxyl, alkoxy of 1 to 6 carbon atoms,                  
             trifluoromethoxy or alkyl of 1 to 6 carbon atoms;                                                        
                    R  is hydrogen, halogen, alkoxy of 1 to 6 carbon atoms or alkyl of 1 to 6 carbon                  
                      2                                                                                               
             atoms;                                                                                                   
                    R  is hydrogen, alkyl of 1 to 6 carbon atoms, aryl of 6 to 10 carbon atoms, arylalkyl of          
                      1                                                                                               
             7 to 12 carbon atoms, or benzyl substituted with halogen, carboxyl, alkoxycarbonyl of 2 to 6             
             carbon atoms or aryloxycarbonyl of 7 to 12 carbon atoms,                                                 
             or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.                
                    19.    A method for treating diseases characterized by excessive smooth muscle                    
             cell proliferation in a mammal which comprises administering to that mammal, orally or                   
             parenterally, a smooth muscle proliferation inhibiting amount of a compound of formula I or II:          







                                                          2                                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007